• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

USP22 的异常表达与结直肠癌的肝转移和不良预后相关。

Aberrant expression of USP22 is associated with liver metastasis and poor prognosis of colorectal cancer.

机构信息

Department of Colorectal Surgery, The Affiliated Tumor Hospital of Harbin Medical University, Harbin, PR China.

出版信息

J Surg Oncol. 2011 Mar 1;103(3):283-9. doi: 10.1002/jso.21802. Epub 2010 Dec 8.

DOI:10.1002/jso.21802
PMID:21337558
Abstract

BACKGROUND

The present study was aimed at clarifying the expression of ubiquitin carboxyl-terminal hydrolase 22 (USP22), a novel deubiquitinating enzyme gene, in colorectal cancer (CRC) and its clinical significance.

METHODS

USP22 expression was detected with quantitative RT-PCR, Western blot, and immunohistochemistry (IHC) in 43 CRCs and non-cancerous matched tissues. Furthermore, USP22 protein expression was analyzed in 192 CRC tumors by IHC to evaluate the association with survival.

RESULTS

In 43 paired fresh tissues, the expression level of USP22 was significantly higher in primary CRCs than that in the paired non-cancerous tissues at both mRNA and protein levels (P < 0.0001). Nuclear USP22 expression significantly increased from normal mucosa through adenoma to primary carcinoma (P < 0.0001) and from primary carcinoma to liver metastasis (P = 0.021). The incidence of positive USP22 expression was 54.16% in 192 conventional CRC tissues. Notably, high USP22 expression was significantly associated with shorter disease-specific survival (P < 0.0001) and shorter disease-free survival (P < 0.0001). Cox regression analysis showed USP22 was an independent prognostic parameter for CRC patients.

CONCLUSION

USP22 might be an independent predictive factor for CRC prognosis and aberrant expression of USP22 may play an essential role in colorectal carcinogenesis and liver metastasis.

摘要

背景

本研究旨在阐明泛素羧基末端水解酶 22(USP22)的表达,USP22 是一种新的去泛素化酶基因,在结直肠癌(CRC)及其临床意义中。

方法

采用定量 RT-PCR、Western blot 和免疫组织化学(IHC)检测 43 例 CRC 及配对非癌组织中 USP22 的表达。进一步通过 IHC 分析 192 例 CRC 肿瘤中 USP22 蛋白表达,评估其与生存的关系。

结果

在 43 对新鲜组织中,USP22 的表达水平在原发性 CRC 组织中明显高于配对非癌组织,无论是在 mRNA 水平还是在蛋白水平(P < 0.0001)。USP22 核表达从正常黏膜经腺瘤到原发性癌(P < 0.0001),再从原发性癌到肝转移(P = 0.021)呈显著升高。在 192 例常规 CRC 组织中,USP22 阳性表达的发生率为 54.16%。值得注意的是,USP22 高表达与较短的疾病特异性生存(P < 0.0001)和较短的无病生存(P < 0.0001)显著相关。Cox 回归分析显示,USP22 是 CRC 患者的独立预后参数。

结论

USP22 可能是 CRC 预后的独立预测因子,USP22 的异常表达可能在结直肠发生和肝转移中发挥重要作用。

相似文献

1
Aberrant expression of USP22 is associated with liver metastasis and poor prognosis of colorectal cancer.USP22 的异常表达与结直肠癌的肝转移和不良预后相关。
J Surg Oncol. 2011 Mar 1;103(3):283-9. doi: 10.1002/jso.21802. Epub 2010 Dec 8.
2
USP22 drives colorectal cancer invasion and metastasis via epithelial-mesenchymal transition by activating AP4.USP22 通过激活 AP4,经由上皮-间质转化驱动结直肠癌的侵袭和转移。
Oncotarget. 2017 May 16;8(20):32683-32695. doi: 10.18632/oncotarget.15950.
3
Increased expression of ubiquitin-specific protease 22 can promote cancer progression and predict therapy failure in human colorectal cancer.泛素特异性蛋白酶 22 的表达增加可促进人类结直肠癌的进展,并预测治疗失败。
J Gastroenterol Hepatol. 2010 Nov;25(11):1800-5. doi: 10.1111/j.1440-1746.2010.06352.x.
4
USP22 promotes the G1/S phase transition by upregulating FoxM1 expression via β-catenin nuclear localization and is associated with poor prognosis in stage II pancreatic ductal adenocarcinoma.USP22通过β-连环蛋白核定位上调FoxM1表达来促进G1/S期转变,并且与II期胰腺导管腺癌的不良预后相关。
Int J Oncol. 2014 Oct;45(4):1594-608. doi: 10.3892/ijo.2014.2531. Epub 2014 Jul 3.
5
Overexpression of ubiquitin-specific protease 22 predicts poor survival in patients with early-stage non-small cell lung cancer.泛素特异性蛋白酶 22 的过表达预示着早期非小细胞肺癌患者的生存不良。
Eur J Histochem. 2012 Nov 30;56(4):e46. doi: 10.4081/ejh.2012.e46.
6
Ubiquitin-specific peptidase 22, a histone deubiquitinating enzyme, is a novel poor prognostic factor for salivary adenoid cystic carcinoma.泛素特异性蛋白酶22,一种组蛋白去泛素化酶,是唾液腺腺样囊性癌新的预后不良因素。
PLoS One. 2014 Jan 23;9(1):e87148. doi: 10.1371/journal.pone.0087148. eCollection 2014.
7
Ubiquitin-Specific Peptidase 22 Contributes to Colorectal Cancer Stemness and Chemoresistance via Wnt/β-Catenin Pathway.泛素特异性肽酶22通过Wnt/β-连环蛋白通路促进结直肠癌干性和化疗耐药性。
Cell Physiol Biochem. 2018;46(4):1412-1422. doi: 10.1159/000489156. Epub 2018 Apr 18.
8
Increased expression of USP22 is associated with disease progression and patient prognosis of salivary duct carcinoma.USP22 的表达增加与唾液腺癌的疾病进展和患者预后相关。
Oral Oncol. 2013 Aug;49(8):796-801. doi: 10.1016/j.oraloncology.2013.03.454. Epub 2013 May 9.
9
Abnormal expression of p190RhoGAP in colorectal cancer patients with poor survival.p190RhoGAP在生存状况较差的结直肠癌患者中的异常表达。
Am J Transl Res. 2016 Oct 15;8(10):4405-4414. eCollection 2016.
10
Prognostic significance of USP22 as an oncogene in papillary thyroid carcinoma.USP22作为一种癌基因在甲状腺乳头状癌中的预后意义。
Tumour Biol. 2013 Jun;34(3):1635-9. doi: 10.1007/s13277-013-0696-0. Epub 2013 Feb 15.

引用本文的文献

1
Demethylzeylasteral induces PD-L1 ubiquitin-proteasome degradation and promotes antitumor immunity targeting USP22.去甲基泽拉斯他汀诱导程序性死亡配体1(PD-L1)泛素-蛋白酶体降解并通过靶向泛素特异性蛋白酶22(USP22)促进抗肿瘤免疫。
Acta Pharm Sin B. 2024 Oct;14(10):4312-4328. doi: 10.1016/j.apsb.2024.08.004. Epub 2024 Aug 8.
2
Comprehensive analysis of the role of ubiquitin-specific peptidases in colorectal cancer: A systematic review.泛素特异性肽酶在结直肠癌中的作用的综合分析:一项系统综述
World J Gastrointest Oncol. 2024 Jan 15;16(1):197-213. doi: 10.4251/wjgo.v16.i1.197.
3
Inhibition of USP7 upregulates USP22 and activates its downstream cancer-related signaling pathways in human cancer cells.
USP7 的抑制作用上调了 USP22,并在人类癌细胞中激活了其下游与癌症相关的信号通路。
Cell Commun Signal. 2023 Nov 9;21(1):319. doi: 10.1186/s12964-023-01320-z.
4
Targeted therapy based on ubiquitin-specific proteases, signalling pathways and E3 ligases in non-small-cell lung cancer.基于泛素特异性蛋白酶、信号通路和E3连接酶的非小细胞肺癌靶向治疗
Front Oncol. 2023 Mar 9;13:1120828. doi: 10.3389/fonc.2023.1120828. eCollection 2023.
5
Transcription factor AP2 enhances malignancy of non-small cell lung cancer through upregulation of USP22 gene expression.转录因子 AP2 通过上调 USP22 基因表达增强非小细胞肺癌的恶性程度。
Cell Commun Signal. 2022 Sep 19;20(1):147. doi: 10.1186/s12964-022-00946-9.
6
Immune Evasion and Drug Resistance Mediated by USP22 in Cancer: Novel Targets and Mechanisms.USP22 介导的癌症免疫逃逸和耐药性:新的靶点和机制。
Front Immunol. 2022 Jul 20;13:918314. doi: 10.3389/fimmu.2022.918314. eCollection 2022.
7
Acetylation-dependent SAGA complex dimerization promotes nucleosome acetylation and gene transcription.依赖乙酰化的SAGA复合物二聚化促进核小体乙酰化和基因转录。
Nat Struct Mol Biol. 2022 Mar;29(3):261-273. doi: 10.1038/s41594-022-00736-4. Epub 2022 Mar 17.
8
Deubiquitination in prostate cancer progression: role of USP22.去泛素化在前列腺癌进展中的作用:USP22的作用
J Cancer Metastasis Treat. 2020;6. doi: 10.20517/2394-4722.2020.23. Epub 2020 Jun 18.
9
Emerging Mechanisms and Treatment Progress on Liver Metastasis of Colorectal Cancer.结直肠癌肝转移的新兴机制与治疗进展
Onco Targets Ther. 2021 May 6;14:3013-3036. doi: 10.2147/OTT.S301371. eCollection 2021.
10
Reduced Expression Impairs Mitotic Removal of H2B Monoubiquitination, Alters Chromatin Compaction and Induces Chromosome Instability That May Promote Oncogenesis.表达降低会损害有丝分裂过程中H2B单泛素化的清除,改变染色质压缩状态并诱导染色体不稳定,这可能促进肿瘤发生。
Cancers (Basel). 2021 Mar 2;13(5):1043. doi: 10.3390/cancers13051043.